Cryo-Cell Debt to Equity Ratio 2010-2024 | CCEL
Current and historical debt to equity ratio values for Cryo-Cell (CCEL) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Cryo-Cell debt/equity for the three months ending February 29, 2024 was 0.00.
| Cryo-Cell Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2024-02-29 | $0.07B | $-0.01B | -6.97 |
| 2023-11-30 | $0.07B | $-0.01B | -6.55 |
| 2023-08-31 | $0.07B | $0.00B | -4309.41 |
| 2023-05-31 | $0.07B | $-0.00B | -81.10 |
| 2023-02-28 | $0.07B | $-0.00B | -97.20 |
| 2022-11-30 | $0.07B | $-0.00B | -43.57 |
| 2022-08-31 | $0.07B | $-0.00B | -28.99 |
| 2022-05-31 | $0.05B | $0.00B | 11.57 |
| 2022-02-28 | $0.05B | $0.00B | 11.89 |
| 2021-11-30 | $0.06B | $0.00B | 13.50 |
| 2021-08-31 | $0.06B | $0.01B | 11.38 |
| 2021-05-31 | $0.05B | $0.00B | 13.57 |
| 2021-02-28 | $0.11B | $-0.00B | -63.10 |
| 2020-11-30 | $0.05B | $-0.00B | -18.34 |
| 2020-08-31 | $0.05B | $-0.00B | -12.01 |
| 2020-05-31 | $0.05B | $-0.01B | -10.00 |
| 2020-02-29 | $0.05B | $-0.01B | -8.45 |
| 2019-11-30 | $0.05B | $-0.01B | -7.17 |
| 2019-08-31 | $0.05B | $-0.01B | -7.01 |
| 2019-05-31 | $0.05B | $-0.01B | -6.05 |
| 2019-02-28 | $0.05B | $-0.01B | -6.26 |
| 2018-11-30 | $0.05B | $-0.01B | -5.76 |
| 2018-08-31 | $0.05B | $-0.01B | -5.33 |
| 2018-05-31 | $0.04B | $-0.01B | -2.58 |
| 2018-02-28 | $0.04B | $-0.01B | -2.53 |
| 2017-11-30 | $0.04B | $-0.01B | -2.91 |
| 2017-08-31 | $0.04B | $-0.01B | -2.59 |
| 2017-05-31 | $0.04B | $-0.01B | -2.47 |
| 2017-02-28 | $0.04B | $-0.02B | -2.33 |
| 2016-11-30 | $0.04B | $-0.02B | -2.27 |
| 2016-08-31 | $0.04B | $-0.02B | -2.03 |
| 2016-05-31 | $0.03B | $-0.01B | -5.45 |
| 2016-02-29 | $0.02B | $-0.01B | -4.58 |
| 2015-11-30 | $0.02B | $-0.01B | -4.93 |
| 2015-08-31 | $0.02B | $-0.01B | -5.03 |
| 2015-05-31 | $0.02B | $-0.01B | -2.02 |
| 2015-02-28 | $0.02B | $-0.01B | -2.02 |
| 2014-11-30 | $0.02B | $-0.01B | -1.95 |
| 2014-08-31 | $0.02B | $-0.01B | -1.99 |
| 2014-05-31 | $0.02B | $-0.01B | -2.06 |
| 2014-02-28 | $0.02B | $-0.01B | -2.15 |
| 2013-11-30 | $0.02B | $-0.01B | -2.24 |
| 2013-08-31 | $0.02B | $-0.01B | -2.25 |
| 2013-05-31 | $0.02B | $-0.01B | -2.27 |
| 2013-02-28 | $0.02B | $-0.01B | -2.37 |
| 2012-11-30 | $0.02B | $-0.01B | -2.37 |
| 2012-08-31 | $0.02B | $-0.01B | -2.55 |
| 2012-05-31 | $0.02B | $-0.01B | -2.71 |
| 2012-02-29 | $0.02B | $-0.01B | -4.59 |
| 2011-11-30 | $0.02B | $-0.00B | -8.91 |
| 2011-08-31 | $0.02B | $-0.00B | -8.81 |
| 2011-05-31 | $0.02B | $0.00B | -53.71 |
| 2011-02-28 | $0.02B | $-0.00B | -31.63 |
| 2010-11-30 | $0.02B | $-0.00B | -19.06 |
| 2010-08-31 | $0.02B | $-0.00B | -9.85 |
| 2010-05-31 | $0.02B | $-0.00B | -4.44 |
| 2010-02-28 | $0.02B | $-0.01B | -4.03 |
| 2009-11-30 | $0.02B | $-0.01B | -3.82 |
| 2009-08-31 | $0.02B | $-0.01B | -3.73 |
| 2009-05-31 | $0.02B | $-0.01B | -3.27 |
| 2009-02-28 | $0.02B | $-0.01B | -2.81 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.073B | $0.031B |
| CRYO-CELL International is engaged in cryogenic cellular storage and the design and developmentof cellular storage devices. They currently focus on the processing and preservation of umbilical cord blood stem cells for autologous/sibling use. They have pioneered several technologies that allow for the processing and storage of specimens in a cryogenic environment, and presently, their mission of affordability for U-Cord blood preservation remains in effect. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $126.810B | 15.91 |
| Cencora (COR) | United States | $43.297B | 16.88 |
| ICON (ICLR) | Ireland | $26.224B | 24.76 |
| DiDi Global (DIDIY) | China | $22.844B | 0.00 |
| Avantor (AVTR) | United States | $16.914B | 24.90 |
| CochLear (CHEOY) | Australia | $14.017B | 0.00 |
| Revvity (RVTY) | United States | $13.972B | 24.51 |
| Natera (NTRA) | United States | $13.295B | 0.00 |
| Viatris (VTRS) | United States | $13.050B | 3.90 |
| Medpace Holdings (MEDP) | United States | $12.290B | 40.43 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $11.840B | 0.00 |
| Charles River Laboratories (CRL) | United States | $11.408B | 21.84 |
| Solventum (SOLV) | United States | $10.573B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $7.989B | 0.00 |
| HealthEquity (HQY) | United States | $6.901B | 50.84 |
| Organon (OGN) | United States | $5.619B | 5.33 |
| Doximity (DOCS) | United States | $5.253B | 36.57 |
| Bausch + Lomb (BLCO) | Canada | $5.129B | 20.55 |
| PACS (PACS) | United States | $4.161B | 0.00 |
| Surgery Partners (SGRY) | United States | $3.228B | 29.53 |
| Life Times (LTH) | United States | $3.183B | 33.35 |
| Sotera Health (SHC) | United States | $3.083B | 15.12 |
| GoodRx Holdings (GDRX) | United States | $2.686B | 102.29 |
| Progyny (PGNY) | United States | $2.615B | 45.02 |
| NovoCure (NVCR) | Jersey | $2.448B | 0.00 |
| Agilon Health (AGL) | United States | $2.283B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $2.122B | 8.41 |
| Premier (PINC) | United States | $2.027B | 8.67 |
| Teladoc Health (TDOC) | United States | $2.006B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $1.910B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.496B | 0.00 | |
| Alignment Healthcare (ALHC) | United States | $1.424B | 0.00 |
| Embecta (EMBC) | United States | $0.790B | 5.37 |
| CareDx (CDNA) | United States | $0.788B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.651B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.618B | 6.56 |
| InnovAge Holding (INNV) | United States | $0.616B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.612B | 16.01 |
| GeneDx Holdings (WGS) | United States | $0.542B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.538B | 0.00 |
| Enhabit (EHAB) | United States | $0.465B | 46.35 |
| Sonida Senior Living (SNDA) | United States | $0.441B | 0.00 |
| ModivCare (MODV) | United States | $0.395B | 7.40 |
| MultiPlan (MPLN) | United States | $0.350B | 0.00 |
| Beauty Health (SKIN) | United States | $0.327B | 0.00 |
| LifeMD (LFMD) | United States | $0.326B | 0.00 |
| Sharecare (SHCR) | United States | $0.309B | 0.00 |
| DocGo (DCGO) | United States | $0.306B | 16.72 |
| Sera Prognostics (SERA) | United States | $0.272B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.257B | 0.00 |
| Biodesix (BDSX) | United States | $0.180B | 0.00 |
| So-Young (SY) | China | $0.111B | 37.33 |
| Pono Capital Two (PTWO) | United States | $0.072B | 0.00 |
| NeueHealth (NEUE) | United States | $0.051B | 6.86 |
| IceCure Medical (ICCM) | Israel | $0.050B | 0.00 |
| Oncology Institute (TOI) | United States | $0.044B | 0.00 |
| Nutex Health (NUTX) | United States | $0.036B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.034B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.031B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.030B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
| OncoCyte (OCX) | United States | $0.023B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.014B | 0.00 |
| DermTech (DMTK) | United States | $0.012B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.005B | 0.00 |
| OpGen (OPGN) | United States | $0.004B | 0.00 |
| Assure Holdings (IONM) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |